Medical Cannabis Company Better Is Suing InterCure For $35M

Medical cannabis company Better (Cann Pharmaceuticals Ltd.) is suing InterCure INCR for $35 million.

A lawsuit has been filed against InterCure and its management, adding to a series of lawsuits recently filed against the company's conduct. According to Better, the lawsuit stems from InterCure's alleged attempts to push competitors like Better and other cannabis companies out of the market. Better claims that InterCure has a history of misrepresenting facts to acquisition companies for the purpose of merging and abusing its power in the deal. Better also claims that InterCure has the bad faith of engaging in predatory activities that drain the financial reserves of the acquisition targets.

The lawsuit addresses the actions taken by InterCure's executives during the negotiations with Better, allegedly including making false representations, exerting pressure to transfer commercial materials, damaging production capabilities and harming the company's customers, assets, and means.

Better is asking the court for a number of remedies outlined in its lawsuit, as compensation for InterCure's damages to Better during negotiations.

Photo: Benzinga edit with photos by AJEL and lindsayfox on Pixabay

Related News

InterCure Stock Trading Lower On Q1 Revenue Growth Of 22%, Here Are The Details

Why Are Cannabis Stocks Trading Higher Today?

InterCure Teams Up With TYSON 2.0 In Israel, Australia, United Kingdom, Germany And Other EU Countries